New York State Common Retirement Fund’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $181K | Sell |
17,792
-20,694
| -54% | -$211K | ﹤0.01% | 2293 |
|
|
2025
Q1 | $215K | Buy |
38,486
+22,257
| +137% | +$124K | ﹤0.01% | 2204 |
|
|
2024
Q4 | $131K | Hold |
16,229
| – | – | ﹤0.01% | 2484 |
|
|
2024
Q3 | $166K | Hold |
16,229
| – | – | ﹤0.01% | 2384 |
|
|
2024
Q2 | $115K | Sell |
16,229
-28,485
| -64% | -$202K | ﹤0.01% | 2683 |
|
|
2024
Q1 | $615K | Buy |
44,714
+35,144
| +367% | +$483K | ﹤0.01% | 1999 |
|
|
2023
Q4 | $88K | Sell |
9,570
-6,131
| -39% | -$56.4K | ﹤0.01% | 2803 |
|
|
2023
Q3 | $95K | Buy |
15,701
+401
| +3% | +$2.43K | ﹤0.01% | 2750 |
|
|
2023
Q2 | $119K | Buy |
+15,300
| New | +$119K | ﹤0.01% | 2711 |
|
|
2022
Q3 | – | Sell |
-283
| Closed | -$1K | – | 3401 |
|
|
2022
Q2 | $1K | Sell |
283
-19,300
| -99% | -$68.2K | ﹤0.01% | 3386 |
|
|
2022
Q1 | $105K | Buy |
19,583
+26
| +0.1% | +$139 | ﹤0.01% | 3006 |
|
|
2021
Q4 | $287K | Sell |
19,557
-4,145
| -17% | -$60.8K | ﹤0.01% | 2728 |
|
|
2021
Q3 | $496K | Sell |
23,702
-3,585
| -13% | -$75K | ﹤0.01% | 2468 |
|
|
2021
Q2 | $483K | Buy |
27,287
+5,787
| +27% | +$102K | ﹤0.01% | 2610 |
|
|
2021
Q1 | $527K | Buy |
21,500
+3,100
| +17% | +$76K | ﹤0.01% | 2427 |
|
|
2020
Q4 | $623K | Buy |
18,400
+10,400
| +130% | +$352K | ﹤0.01% | 2243 |
|
|
2020
Q3 | $200K | Hold |
8,000
| – | – | ﹤0.01% | 2644 |
|
|
2020
Q2 | $270K | Buy |
+8,000
| New | +$270K | ﹤0.01% | 2515 |
|